BRIEF-Opgen Announces Acquisition Of Preferred Stock By David Lazar

Reuters03-26

March 25 (Reuters) - OpGen Inc :

* OPGEN ANNOUNCES ACQUISITION OF PREFERRED STOCK BY DAVID LAZAR

* OPGEN INC: DAVID LAZAR WILL TAKE OVER AS CEO OF OPGEN

* OPGEN INC: SETTLES OUTSTANDING LIABILITIES WITH EIB

* OPGEN: GOT INTO SECURITIES PURCHASE DEAL WITH DAVID LAZAR POST WHICH HE TO BUY 3 MILLION SHARES OF SERIES E PREFERRED STOCK AT $1.00/SHARE FOR $3 MILLION

* OPGEN INC: OLIVER SCHACHT, PHD, RESIGNED AS CEO

* OPGEN INC: WILL PAY $2 MILLION OF PROCEEDS FROM FINANCING TO SETTLE ALL OUTSTANDING DEBT OF COMPANY TO EACH OF EIB AND CURETIS

* OPGEN INC: SETTLEMENT AGREEMENT WITH EIB ALSO TERMINATED GUARANTEE AGREEMENT

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2422770577?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-03-26 06:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2422770577","market":"us","top_or_hot":-1,"title":"BRIEF-Opgen Announces Acquisition Of Preferred Stock By David Lazar","media":"Reuters","content":"<html><body><p>March 25 (Reuters) - OpGen Inc   :</p><p>   * OPGEN ANNOUNCES ACQUISITION OF PREFERRED STOCK BY DAVID LAZAR</p><p>   * OPGEN INC: DAVID LAZAR WILL TAKE OVER AS CEO OF OPGEN</p><p>   * OPGEN INC: SETTLES OUTSTANDING LIABILITIES WITH EIB</p><p>   * OPGEN: GOT INTO SECURITIES PURCHASE DEAL WITH DAVID LAZAR POST WHICH HE TO BUY 3 MILLION SHARES OF SERIES E PREFERRED STOCK AT $1.00/SHARE FOR $3 MILLION</p><p>   * OPGEN INC: OLIVER SCHACHT, PHD, RESIGNED AS CEO</p><p>   * OPGEN INC: WILL PAY $2 MILLION OF PROCEEDS FROM FINANCING TO SETTLE ALL OUTSTANDING DEBT OF COMPANY TO EACH OF EIB AND CURETIS</p><p>   * OPGEN INC: SETTLEMENT AGREEMENT WITH EIB ALSO TERMINATED GUARANTEE AGREEMENT</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Opgen Announces Acquisition Of Preferred Stock By David Lazar</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Opgen Announces Acquisition Of Preferred Stock By David Lazar\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-26 06:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>March 25 (Reuters) - OpGen Inc   :   * OPGEN ANNOUNCES ACQUISITION OF PREFERRED STOCK BY DAVID LAZAR   * OPGEN INC: DAVID LAZAR WILL TAKE OVER AS CEO OF OPGEN   * OPGEN INC: SETTLES OUTSTANDING ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2422770577","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2422770577","pubTimestamp":1711405691,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"March 25  - OpGen Inc   :   * OPGEN ANNOUNCES ACQUISITION OF PREFERRED STOCK BY DAVID LAZAR   * OPGEN INC: DAVID LAZAR WILL TAKE OVER AS CEO OF OPGEN   * OPGEN INC: SETTLES OUTSTANDING LIABILITIES WITH EIB   * OPGEN: GOT INTO SECURITIES PURCHASE DEAL WITH DAVID LAZAR POST WHICH HE TO BUY 3 MILLION SHARES OF SERIES E PREFERRED STOCK AT $1.00/SHARE FOR $3 MILLION   * OPGEN INC: OLIVER SCHACHT, PHD, RESIGNED AS CEO   * OPGEN INC: WILL PAY $2 MILLION OF PROCEEDS FROM FINANCING TO SETTLE ALL OUTSTANDING DEBT OF COMPANY TO EACH OF EIB AND CURETIS   * OPGEN INC: SETTLEMENT AGREEMENT WITH EIB ALSO TERMINATED GUARANTEE AGREEMENTSource text for Eikon:    Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","OPGN":"OpGen, Inc."},"translate_title":"简介-Opgen宣布大卫·耶戈收购优先股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OPGN":1},"content_text":"March 25 (Reuters) - OpGen Inc   :   * OPGEN ANNOUNCES ACQUISITION OF PREFERRED STOCK BY DAVID LAZAR   * OPGEN INC: DAVID LAZAR WILL TAKE OVER AS CEO OF OPGEN   * OPGEN INC: SETTLES OUTSTANDING LIABILITIES WITH EIB   * OPGEN: GOT INTO SECURITIES PURCHASE DEAL WITH DAVID LAZAR POST WHICH HE TO BUY 3 MILLION SHARES OF SERIES E PREFERRED STOCK AT $1.00/SHARE FOR $3 MILLION   * OPGEN INC: OLIVER SCHACHT, PHD, RESIGNED AS CEO   * OPGEN INC: WILL PAY $2 MILLION OF PROCEEDS FROM FINANCING TO SETTLE ALL OUTSTANDING DEBT OF COMPANY TO EACH OF EIB AND CURETIS   * OPGEN INC: SETTLEMENT AGREEMENT WITH EIB ALSO TERMINATED GUARANTEE AGREEMENTSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2422770577"}